During the past decade, Newark Radiation Oncology conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 64 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 43 clinical trials were completed. i.e. 215% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newark Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "GOG Foundation" with 11 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newark Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Newark Radiation Oncology" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Fallopian Tube Carcinoma" (6 trials) and "Recurrent Primary Peritoneal Carcinoma" (6 trials). Many other conditions were trialed in "Newark Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Newark Radiation Oncology" are "Drug" (122 trials), "Other" (107 trials), "Biological" (65 trials), "Procedure" (38 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (44 trials), "Questionnaire Administration" (25 trials), "Computed Tomography" (22 trials) and "Biospecimen Collection" (21 trials). Other intervention names were less common.

The vast majority of trials in "Newark Radiation Oncology" are 121 trials for "All" genders, 37 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Newark Radiation Oncology". undefined are not yet recruiting, 36 are recruiting, 84 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Newark Radiation Oncology, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Newark Radiation Oncology, 6 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".